Subscribe to RSS
DOI: 10.1055/s-2004-832618
© Georg Thieme Verlag KG Stuttgart · New York
Gene Expression Profiles of Inducible Nitric Oxide Synthase and Cytokines in Leishmania major-Infected Macrophage-Like RAW 264.7 Cells Treated with Gallic Acid
Publication History
Received: April 6, 2004
Accepted: July 28, 2004
Publication Date:
18 October 2004 (online)
Abstract
The effects of gallic acid on the gene expressions of inducible nitric oxide synthase (iNOS) and the cytokines interleukin (IL)-1, IL-10, IL-12, IL-18, TNF-α, and interferon (IFN)-γ were investigated by reverse-transcription polymerase chain reaction (RT-PCR). The experiments were performed in parallel in non-infected and in L. major-infected RAW 264.7 cells and the expression profiles were compared with those mediated by IFN-γ plus lipopolysaccharide (LPS). The infection per se induced the expression first of IL-1 and TNF-α mRNA, later that of IL-10 mRNA. Gallic acid induced low and transient levels of TNF-α and IL-10 in non-infected cells, and it clearly enhanced and prolonged iNOS and cytokine mRNA expressions in Leishmania-parasitised cells. Interestingly, and in contrast to activation by IFN-γ/LPS, gallic acid also stimulated Leishmania-infected cells to produce IFN-γ mRNA. For IFN-α, a sandwich immunoassay was performed to determine its amount present in the supernatant of gallic acid-stimulated RAW 264.7 cells. In showing predominant stimulation of infected cells and the induction especially of IFN-γ, a cytokine that plays a central role in antimicrobial macrophage and T cell regulation, these data provide the basis for an immunological concept of gallic acid and possibly other plant polyphenols for their beneficial effects in various infectious conditions.
Key words
Leishmania major - Macrophages - gallic acid - inducible nitric oxide synthase - cytokines
References
- 1 Ashford R W, Desjeux P, DeRaadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today. 1992; 8 104-5
- 2 Hepburn N C. Management of cutaneous leishmaniasis. Curr Opin Infect Dis. 2001; 14 151-4
- 3 Reiner S L, Locksley R M. The regulation of immunity to Leishmania major . Annu Rev Immunol. 1995; 13 151-77
-
4 Wagner H, Proksch A. Immunostimulatory drugs of fungi and higher plants. In: Farnsworth N, Wagner H, editors
Economic and Medicinal Plant Research . Vol. 1 Academic Press London; 1985: pp 113-53 - 5 Chan-Bacab M J, Pena-Rodriguez L M. Plant natural products with leishmanicidal activity. Nat Prod Rep. 2001; 18 674-88
- 6 Kolodziej H, Kayser O, Kiderlen A F, Ito H, Hatano T, Yoshida T, Foo L Y. Antileishmanial activity of hydrolyzable tannins and their modulatory effects on nitric oxide and tumour necrosis factor-α release in macrophages in vitro . Planta Med. 2001; 67 825-32
- 7 Kiderlen A F, Kayser O, Ferreira D, Kolodziej H. Tannins and related compounds: killing of amastigotes of Leishmania donovani and release of nitric oxide and tumour necrosis factor α in macrophages in vitro . Z Naturforsch. 2001; 56c 444-54
- 8 Kolodziej H, Kayser O, Kiderlen A F, Ito H, Hatano T, Yoshida T, Foo L Y. Proanthocyanidins and related compounds: antileishmanial activity and modulatory effects on nitric oxide and tumor necrosis factor-α-release in the murine macrophage-like cell line RAW 264.7 Biol Pharm Bull. 2001; 24 1016-21
- 9 Staehelin T, Stähli C, Hobbs D S, Pestka S. A rapid quantitative assay of high sensitivity for human leukocyte interferon with monoclonal antibodies. In: Pestka S, editor. Methods in Enzymology. New York: Academic Press,. 1981; 79 pp 589-95
- 10 Mauel J, Ransijn A. Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products. Exp Parasitol. 1997; 87 98-111
- 11 Beutler B, Cerami A. The biology of cachectin/TNF: a primary mediator of host response against a human tumour necrosis factor-α receptor. Annu Rev of Immunol. 1989; 7 625-55
- 12 Zidek Z, Tuckova L, Mara M, Barot-Ciorbaru R, Prokesova L, Tlaskalova-Hogenova H. Stimulation of macrophages by Bacillus firmus: production of nitric oxide and cytokines. Int J Immunopharmacol. 1998; 20 359-368
- 13 Galvani D W, Cawley J C. Cytokine Therapy. Cambridge University Press Cambridge; 1992
- 14 Alexander J, Satoskar A R, Russell D G. Leishmania species: models of intracellular parasitism. J Cell Sci. 1999; 112 2993-3002
- 15 Sugawara I. Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens. Microbes Infect. 2000; 2 1257-63
- 16 Mocellin S, Panelli M C, Wang E, Nagorsen D, Marincola F M. The dual role of IL-10. Trends Immunol. 2003; 24 36-8
- 17 Billiau A. Interferon-γ: biology and role in pathogenesis. Adv Immunol. 1995; 62 61-130
- 18 Mogensen S C, Virelizier J L. The interferon-macrophage alliance. Interferon. 1987; 8 55-84
- 19 Gessani S, Belardelli F. IFN-γ expression in macrophages and its possible biological significance. Cytokine Growth F R. 1998; 9 117-23
- 20 Liew F Y, O'Donnell C A. Immunology of leishmaniasis. Adv Parasitol. 1993; 32 161-259
- 21 Liew F Y, Wei X Q, Proudfoot L. Cytokines and nitric oxide as effector molecules against parasitic infections. Philos T Roy Soc B. 1997; 352 1311-5
Professor Dr. Herbert Kolodziej
Institut für Pharmazie
Pharmazeutische Biologie
Freie Universität Berlin
Königin-Luise-Str. 2+4
14195 Berlin
Germany
Fax: +49-30-838-53729
Email: kolpharm@zedat.fu-berlin.de